Frederick Millard
University of California San Diego(US)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Testicular diseases and treatments, Renal cell carcinoma treatment, Immunotherapy and Immune Responses, Cancer Genomics and Diagnostics
Most-Cited Works
- → Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP(1987)313 cited
- → Adolescent and Young Adult Oncology, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology(2018)294 cited
- → Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinoma(2014)111 cited
- → Feasibility and efficacy of neoadjuvant sunitinib before nephron‐sparing surgery(2010)105 cited
- → Gemcitabine for malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B(2001)101 cited
- Circulating HER-2/erbB-2/c-neu (HER-2) extracellular domain as a prognostic factor in patients with metastatic breast cancer: Cancer and Leukemia Group B Study 8662.(2001)
- → Prospective Evaluation of the Relationship of Patient Age and Paclitaxel Clinical Pharmacology: Cancer and Leukemia Group B (CALGB 9762)(2006)91 cited
- → Molecular aberrations, targeted therapy, and renal cell carcinoma: current state-of-the-art(2014)80 cited
- → Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men with Hormone-Sensitive Biochemically Recurrent Prostate Cancer: A Phase II Randomized Trial(2016)77 cited
- → Neoadjuvant therapy for localized and locally advanced renal cell carcinoma(2017)76 cited